Groundbreaking

COVID-19 Pathogen Adsorption Therapy

ExThera Medical’s Seraph® 100 Microbind® Affinity Blood Filter is a groundbreaking hemoperfusion technology that addresses unmet clinical needs for treating severe COVID-19.

An Exciting Option for Critical Care Teams

The Seraph 100 uses microbead adsorption media with chemically-bonded modified heparin to mimic the binding sites that COVID-19 uses when they invade the bloodstream. COVID-19 is removed from the bloodstream, and once bound, remains in the filter.

Seraph 100 Mechanism of Action: How it works

MM-00017 Rev F